XML 61 R50.htm IDEA: XBRL DOCUMENT v3.7.0.1
Subsequent events (Details) - USD ($)
May 05, 2017
Apr. 20, 2017
Non-collaborative Arrangement Transactions | Marathon Pharmaceuticals, LLC | Subsequent Event    
Subsequent Event [Line Items]    
Consideration transferred   $ 140,000,000
Payments to acquire businesses   $ 75,000,000
Equity Interest Issued, number of shares (in shares)   6,683,598
Scenario, Forecast | Non-collaborative Arrangement Transactions | Marathon Pharmaceuticals, LLC    
Subsequent Event [Line Items]    
Development and regulatory milestone payments which the entity may be obligated to pay   $ 50,000,000
MidCap Financial Trust | Term Loan Facility | Subsequent Event    
Subsequent Event [Line Items]    
Line of credit facility, maximum borrowing capacity $ 60,000,000  
Proceeds from lines of credit 40,000,000  
Line of credit facility, additional capacity available, net product revenue threshold 20,000,000  
Line of credit facility, net product revenue threshold, additional capacity 120,000,000  
Line of credit facility, net product revenue threshold $ 100,000,000  
London Interbank Offered Rate (LIBOR) | MidCap Financial Trust | Term Loan Facility | Subsequent Event    
Subsequent Event [Line Items]    
Debt instrument, floor interest rate 1.00%  
Debt instrument, basis spread on variable rate 6.15%